Revolution Medicines (RVMD) Interest & Investment Income: 2019-2025
Historic Interest & Investment Income for Revolution Medicines (RVMD) over the last 7 years, with Sep 2025 value amounting to $22.1 million.
- Revolution Medicines' Interest & Investment Income rose 8.19% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.6 million, marking a year-over-year increase of 7.08%. This contributed to the annual value of $86.9 million for FY2024, which is 82.98% up from last year.
- Revolution Medicines' Interest & Investment Income amounted to $22.1 million in Q3 2025, which was down 1.43% from $22.4 million recorded in Q2 2025.
- Revolution Medicines' 5-year Interest & Investment Income high stood at $24.9 million for Q1 2025, and its period low was $223,000 during Q3 2021.
- Its 3-year average for Interest & Investment Income is $18.5 million, with a median of $21.2 million in 2024.
- Its Interest & Investment Income has fluctuated over the past 5 years, first slumped by 74.37% in 2021, then soared by 2,237.42% in 2023.
- Quarterly analysis of 5 years shows Revolution Medicines' Interest & Investment Income stood at $237,000 in 2021, then skyrocketed by 2,042.19% to $5.1 million in 2022, then spiked by 273.78% to $19.0 million in 2023, then increased by 11.85% to $21.2 million in 2024, then climbed by 8.19% to $22.1 million in 2025.
- Its Interest & Investment Income was $22.1 million in Q3 2025, compared to $22.4 million in Q2 2025 and $24.9 million in Q1 2025.